Levosimendan in Congenital Cardiac Surgery

Trial Profile

Levosimendan in Congenital Cardiac Surgery

Phase of Trial: Phase II

Latest Information Update: 27 Jan 2010

At a glance

  • Drugs Levosimendan (Primary) ; Milrinone
  • Indications Low cardiac output
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Nov 2008 Status changed from not yet recruiting to recruiting.
    • 09 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top